What is HC Wainwright’s Forecast for ZVRA Q1 Earnings?
HC Wainwright issued their Q1 2025 EPS estimates for shares of Zevra Therapeutics in a note issued to investors on Thursday, ...
HC Wainwright Reaffirms Buy Rating for ImmunityBio (NASDAQ:IBRX)
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in ...
ProQR Therapeutics price target raised to $12 from $10 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on ProQR Therapeutics (PRQR) to $12 from $10 and keeps a Buy rating on the shares. The firm says ...
IN8bio price target lowered to $6 from $8 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on IN8bio (INAB) to $6 from $8 and keeps a Buy rating on the ...
Stocktwits on MSN3d
Core Scientific Stock Gains As HC Wainwright Reiterates Rating On CoreWeave's $12B OpenAI Deal: Retail Stays Extremely Bullish
Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...
Fintel on MSN1d
HC Wainwright & Co. Initiates Coverage of Perspective Therapeutics (CATX) with Buy Recommendation
Fintel reports that on March 13, 2025, HC Wainwright & Co. initiated coverage of Perspective Therapeutics (NYSEAM:CATX) with ...
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
H.C. Wainwright & Co. initiates a Buy rating on Perspective Therapeutics, citing promising cancer radiotherapy assets.
CoinDesk3d
U.S. Strategic Bitcoin Reserve a 'Monumental Endorsement' of the Crypto: H.C. Wainwright
The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...
Nanoscope Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Showcase
Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision ...
H.C. Wainwright says Novo results support Viking obesity potential
REDEFINE-2 results reinforce Viking Therapeutics’ (VKTX) VK2735’s potential in obesity and beyond. Assuming full adherence, Novo’s CagriSema achieved 15.7% weight loss compared to 3.1% with placebo, ...
Nasdaq11d
HC Wainwright & Co. Initiates Coverage of Surf Air Mobility (SRFM) with Buy Recommendation
Fintel reports that on March 7, 2025, HC Wainwright & Co. initiated coverage of Surf Air Mobility (NYSE:SRFM) with a Buy recommendation. As of March 4, 2025, the average one-year price target for ...
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
A live webcast and replay will be available under "Events and Presentations" in the News & Presentations section of the IN8bio website at IN8bio is a clinical-stage biopharmaceutical company ...